FOLR1 and cancer: In recent clinical studies, antifolates such as methotrexate (MTX), pemetrexed (PTX), pralatrexate (PDX), raltitrexed (RTX), and edatrexate (EDX) bound to FRα and killed cancer cells [30,31,32].